T Cell Metabolism in Cancer Immunotherapy

Immune checkpoint therapies aiming to enhance T cell responses have revolutionized cancer immunotherapy. However, although a small fraction of patients develops durable anti-tumor responses, the majority of patients display only transient responses, underlying the need for finding auxiliary approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Aksoylar, Halil-Ibrahim, Tijaro-Ovalle, Natalia M., Boussiotis, Vassiliki A., Patsoukis, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341973/
https://www.ncbi.nlm.nih.gov/pubmed/32642279
http://dx.doi.org/10.20900/immunometab20200020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341973/
https://www.ncbi.nlm.nih.gov/pubmed/32642279
http://dx.doi.org/10.20900/immunometab20200020

Ejemplares similares